Related by context. All words. (Click for frequent words.) 67 ASCUS 65 CIN2 + 63 histologic subtype 63 CIN2 62 leiomyomas 62 grade squamous intraepithelial 62 abnormal cytology 62 advanced adenoma 62 grade cervical intraepithelial 61 cervical intraepithelial neoplasia 61 seronegative 61 pT2 61 invasive ductal 61 HGPIN 61 endometrial carcinoma 61 CIN3 61 external genital lesions 60 gastric adenocarcinoma 60 PCa 60 colorectal neoplasms 60 adenomatous polyps 60 HER2 expression 60 cervical carcinoma 60 nonmelanoma skin cancer 60 microscopic hematuria 59 seropositivity 59 lymphocytosis 59 atypical ductal hyperplasia 59 invasive carcinomas 59 proctitis 59 Human papillomavirus 59 neoplasia 59 intestinal metaplasia 59 prostate cancer CaP 59 recurrent VTE 59 total thyroidectomy 59 SLNB 59 definite stent thrombosis 59 HBsAg 58 CIN3 + 58 rebleeding 58 advanced adenomas 58 Neisseria gonorrhoeae 58 serum prostate 58 neoplasm 58 malignant neoplasm 58 genital herpes infections 58 bacteriuria 58 Asymptomatic 58 cervical cytology 58 atrophic gastritis 58 Trichomonas vaginalis 58 thromboembolic events 58 virologic failures 58 cutaneous melanoma 58 colorectal adenoma 58 urothelial carcinoma 58 vaginal lesions 58 periprocedural MI 58 adenoma 58 neoplasms 58 HIV seropositive 58 HBeAg 58 pT3 58 advanced neoplasia 58 Adenomas 58 ALCL 58 chlamydial infection 58 intravesical therapy 58 clinico pathological 58 FluCAM arm 58 carotid stenosis 57 mesotheliomas 57 nonmelanoma skin cancers 57 radical prostatectomy RP 57 grade cervical dysplasia 57 ertapenem 57 latent tuberculosis infection 57 Chlamydia trachomatis infection 57 pCR 57 Human papilloma virus 57 NMIBC 57 serum folate concentrations 57 EUS FNA 57 anal cancers 57 radical nephrectomy 57 neoplasias 57 BRCA2 mutation carriers 57 confidence intervals CIs 57 ano genital warts 57 colorectal polyp 57 hepatocellular carcinomas 57 elevated ALT 57 situ DCIS 57 squamous cell carcinoma SCC 57 LTBI 57 hemagglutination inhibition 57 elevated LDH 57 gastric carcinoma 57 thromboembolic complications 57 varicoceles 57 antibody titer 57 NP CRNs 57 asymptomatic carriers 57 lymphadenectomy 57 HPV# 57 invasive aspergillosis 57 CP CPPS 57 colorectal carcinomas 56 breast carcinomas 56 hyperplastic 56 skeletal metastases 56 PSA nadir 56 perioperative mortality 56 candidemia 56 Squamous 56 erythrocyte sedimentation rate 56 cervical dysplasia 56 nonmetastatic 56 serum PSA 56 situ LCIS 56 coinfection 56 CC genotype 56 biochemical recurrence 56 invasive carcinoma 56 squamous 56 colorectal cancer incidence 56 thyroid nodules 56 colorectal cancer CRC 56 epithelial tumors 56 undergone radical prostatectomy 56 genital ulcers 56 HBeAg negative 56 TEAEs 56 ductal cancer 56 precancerous cervical lesions 56 undetectable HBV DNA 56 colorectal carcinoma 56 malignant lesions 56 endometrial hyperplasia 56 malignant nodules 56 LV dysfunction 56 MRSA colonization 56 ductal breast cancer 56 invasive cervical cancer 56 Cervista HPV 56 adenoma recurrence 56 albumin excretion rate 56 elevated CRP 56 HIV uninfected 56 Uterine fibroids 56 Helicobacter pylori infection 56 basal cell carcinoma BCC 56 cervical lesions 56 osteosarcomas 56 lobular carcinomas 56 coinfected 56 histologically confirmed 56 atypical hyperplasia 55 BCG vaccinated 55 BRCA2 mutations 55 LVNC 55 Daptomycin 55 antigen PSA levels 55 pretest probability 55 adrenalectomy 55 Cytogenetic 55 cervical adenocarcinoma 55 micafungin 55 soft tissue sarcomas 55 Papillary 55 endometrial thickness 55 C. trachomatis 55 extracapsular extension 55 S aureus 55 seroprevalence 55 sustained virological response 55 NRTI resistance 55 epithelial ovarian cancer 55 caspofungin 55 chronic HBV infection 55 carcinomas 55 intraepithelial neoplasia 55 bacteraemia 55 polyposis 55 ischemic lesions 55 thromboembolism 55 malignant polyps 55 K#N 55 extracolonic findings 55 odds ratios ORs 55 locoregional recurrence 55 multivariable adjusted 55 BRCA1 mutation carriers 55 HPV-#/# 55 ovarian carcinoma 55 prostate carcinoma 55 thyroglobulin 55 RhD negative 55 subclinical hyperthyroidism 55 HRCT 55 Immunohistochemical staining 55 cervicitis 55 antiandrogens 55 abnormal Pap 55 abnormal pap smears 55 mucinous 55 NNRTI resistance 55 HPV subtypes 55 enterococcal 55 dysplastic lesions 55 ultrasonographic 55 XIENCE V PROMUS Stent 55 Chlamydia infections 55 anal lesions 55 HNSCC 55 renal cell carcinomas 55 renal tumors 55 lobular carcinoma 55 CMV infection 55 HCV infections 55 atypia 55 neoplastic lesions 55 HBeAg seroconversion 55 invasive candidiasis 55 papillary carcinoma 55 papillary thyroid carcinoma 55 chronic HBV 55 mammographic density 55 RhD 55 thyroid carcinoma 54 ADPKD 54 dysglycemia 54 rs# [002] 54 subclinical 54 spontaneous preterm delivery 54 node metastases 54 Cervista HPV HR 54 completely resected 54 axillary lymph nodes 54 endometrial cancers 54 S. aureus isolates 54 precursor lesions 54 parasitaemia 54 chronic prostatitis 54 Human papillomavirus HPV 54 urethritis 54 FDG uptake 54 onset diabetes mellitus 54 seminal vesicle invasion 54 Chlamydia trachomatis 54 anterior uveitis 54 resectable 54 euthyroid 54 BCCs 54 oropharyngeal cancer 54 Febrile neutropenia 54 stage IIIB 54 Subgroup analyzes 54 neoplasia CIN 54 HER2 overexpression 54 microbiological eradication 54 oropharyngeal cancers 54 nonalcoholic steatohepatitis NASH 54 histological subtype 54 uterine cervix 54 rs# [004] 54 allele frequencies 54 genotypic resistance 54 Human Papillomavirus 54 NMP# 54 anti JCV antibodies 54 Stent thrombosis 54 HCV genotype 54 SUVmax 54 anogenital warts 54 binary restenosis 54 hydronephrosis 54 histologically 54 CsA 54 alanine aminotransferase 54 mRCC 54 metastatic malignant 54 anal HPV 54 enteroviral 54 seroconverted 54 deletion 5q 54 endophthalmitis 54 coronary stenosis 54 Heavy menstrual bleeding 54 #.#ng/ml 54 Histologic 54 mediastinitis 54 lymph node metastasis 54 severe rotavirus gastroenteritis 54 Non inferiority 54 premalignant 54 Chlamydia pneumoniae 54 transurethral resection 54 precancerous cervical 54 rs# [001] 54 genotype 1b 54 perinatal mortality 54 chlamydial 54 GISTs 54 clade B 54 HCV infection 54 PHPT 54 seroprotection 54 prolonged QT interval 54 sero positive 54 aged ≥ 54 HOMA IR 54 BSIs 54 HBV infection 53 Kruskal Wallis test 53 BRCA mutation carriers 53 malignant pleural mesothelioma 53 patients undergoing CABG 53 baseline LDH 53 sonographic findings 53 specific antigen PSA 53 Actinic Keratosis 53 cytogenetic abnormalities 53 transitional cell carcinoma 53 castrate resistant 53 T2DM 53 subclinical atherosclerosis 53 Prostatitis 53 severe neutropenia 53 abnormal Pap smear 53 Serologic 53 KRAS mutations occur 53 PAOD 53 thymoma 53 nodal metastases 53 microsatellite instability 53 relapsed MM 53 extracranial 53 % CI #.#-#.# [008] 53 nodal metastasis 53 histologic subtypes 53 lung carcinomas 53 gastroduodenal 53 HER2 amplification 53 lymphadenopathy 53 pre cancerous lesions 53 radiographic findings 53 carcinoids 53 H pylori 53 Hepatitis B Virus 53 abnormal Pap smears 53 Bacteremia 53 hepatocellular cancer 53 Human Papillomavirus HPV 53 serogroup 53 penile cancers 53 vulvar cancer 53 noninferior 53 neutrophil counts 53 breast carcinoma 53 cirrhotic patients 53 recurrent metastatic 53 cutaneous squamous cell carcinoma 53 rectal gonorrhea 53 Kaplan Meier analysis 53 fetal malformations 53 distal colon cancer 53 MGUS 53 ocular toxicity 53 HCV antibody 53 T1c 53 Virologic 53 Epstein Barr virus EBV 53 perianal 53 heterozygotes 53 Recurrences 53 polyp recurrence 53 TT genotype 53 glomerular filtration 53 NSTEMI 53 colorectal adenocarcinoma 53 Serological 53 HBeAg positive 53 mutated BRCA1 53 biochemical relapse 53 gene BRCA2 53 obstructive coronary 53 perimenopausal women 53 intraclass correlation coefficient 53 peritoneal cancer 53 histologic 53 Enterobacteriaceae 53 IgA deficiency 53 sonographically 53 vaginal cancers 53 Escherichia coli Klebsiella pneumoniae 53 trichomonas 53 mIU ml 53 viraemia 53 serous ovarian cancer 53 leukocytosis 53 intracranial hemorrhage ICH 53 Nasopharyngeal 53 GABHS 53 genital HPV infection 53 grade dysplasia 53 ipsilateral stroke 53 % Confidence Interval 53 expressors 53 adenomatous 53 carotid plaque 53 invasive lobular 53 bioavailable testosterone 53 grade cervical lesions 53 hip BMD 53 oral squamous cell 53 DXA scan 53 Malignant Melanoma 53 Onychomycosis 53 HNPCC 53 seroconversion 53 ALT elevation 53 urolithiasis 53 meropenem 53 myelodysplastic myeloproliferative diseases 53 precancers 53 chronic periodontitis 53 operable breast cancer 53 vesicoureteral reflux 53 contralateral breast cancer 53 germline mutations 53 recurrent UTI 53 Anaplastic 53 coinfections 53 gonorrhea infections 53 vaccinees 53 LV ejection fraction 53 gonococcal infections 53 ALND 53 meningiomas 53 vertebral fracture 53 plain radiographs 52 chorioamnionitis 52 Leukemias 52 doxorubicin docetaxel 52 serotype #A 52 hemorrhagic cystitis 52 MetS 52 hamartomas 52 immunocompetent 52 immunoreactivity 52 J. Clin 52 pelvic lymphadenectomy 52 psychiatric morbidity 52 prostate cancer PCa 52 cTnT 52 lumbar spine BMD 52 Ki# 52 metastatic prostate 52 flutamide 52 metachronous 52 albumin excretion 52 liposomal amphotericin B 52 PSADT 52 M#V 52 angiographically 52 allele frequency 52 transaminase elevations 52 fluoroquinolone resistant 52 moderately emetogenic 52 acute aortic dissection 52 chlamydial infections 52 dose Iluvien 52 BRCA mutations 52 asymptomatic 52 mL/min/#.# m 2 52 intact parathyroid hormone 52 gonococcal 52 KRAS wild 52 Venous thromboembolism 52 Enterobacter cloacae 52 ECG abnormalities 52 PCA3 52 proximal colon 52 immunostaining 52 S. aureus bacteremia 52 Peripheral arterial disease 52 underwent resection 52 rheumatoid factor 52 hydroxyvitamin D levels 52 Endometrial cancer 52 homocysteine concentrations 52 adiponectin concentrations 52 alanine aminotransferase ALT 52 bronchoalveolar lavage 52 gonorrhoeae 52 paragangliomas 52 seropositive 52 undergoing radical prostatectomy 52 INVANZ 52 NIH CPSI 52 stenoses 52 D dimer 52 cTnT levels 52 choriocarcinoma 52 cEVR 52 coronary calcification 52 perioperative complications 52 metastatic neuroendocrine tumors 52 pheochromocytomas 52 adnexal mass 52 vulvovaginal candidiasis 52 chronic HCV 52 microvessel density 52 leiomyoma 52 renal artery stenosis 52 ovarian pancreatic 52 varicocele 52 chronic hepatitis cirrhosis 52 multivariable analysis 52 nonpregnant women 52 clinically insignificant 52 bone metastasis 52 superinfection 52 Alferon LDO 52 virus HBV 52 BRCA2 carriers 52 VUR 52 nonvaccine 52 serologic testing 52 transthyretin amyloidosis 52 serologically 52 B Cell Lymphoma 52 hematologic toxicity 52 myeloperoxidase 52 HIV HCV coinfected 52 invasive cervical cancers 52 clinicopathologic 52 Catheter Associated 52 H. influenzae 52 DAS# CRP 52 prostate specific 52 M#V mutation 52 HPV infections 52 vulvar intraepithelial neoplasia 52 overt hypothyroidism 52 invasive meningococcal disease 52 postoperative morbidity 52 vulvar vaginal 52 POAG 52 hypogonadal 52 antigen PSA 52 Enterococcus faecium 52 β blockers 52 ARB telmisartan 52 piperacillin tazobactam 52 serum ALT 52 MALT lymphoma 52 R5 tropic 52 tigecycline 52 pleural effusions 52 thrombotic complications 52 postexposure prophylaxis 52 liver histology 52 BRCA1 mutations 52 oropharyngeal candidiasis 52 penetrance 52 ximelagatran 52 pheochromocytoma 52 neoplastic 52 oocytes retrieved 52 hematuria 52 IL#B 52 K ras mutations 52 bacterial vaginosis BV 52 CMV disease 52 Genotypes 52 pulmonary metastases 52 colorectal neoplasia 52 CTEPH 52 pmol L 52 estimated glomerular filtration 52 acute rheumatic fever 52 T1a 52 cytopathic 52 squamous cell carcinomas 52 highest tertile 51 μmol L 51 differentiated thyroid 51 univariate 51 anti HBs 51 elevated triglyceride levels 51 acute leukemias 51 Plasmodium ovale 51 GARDASIL ® 51 Lymphocytic 51 seminoma 51 mediastinal 51 log# copies mL 51 serologic 51 proliferative diabetic retinopathy 51 anogenital 51 homozygotes 51 lupus anticoagulant 51 vulvar cancers 51 folate concentrations 51 mutated KRAS gene 51 pericardial effusion 51 cancerous cervical lesions 51 poor metabolizers 51 GnRH agonists 51 fluvastatin 51 nonobstructive 51 monoclonal anti 51 etiologic agent 51 lymph node involvement 51 ALT flares 51 methicillin resistant MRSA 51 lactate dehydrogenase 51 AST ALT 51 varicella zoster virus VZV 51 abnormal Pap tests 51 μg L 51 cervical vulvar 51 pulmonary infiltrates 51 acid phosphatase PAP 51 CHD mortality 51 osteopenic 51 thyroid dysfunction 51 lymphocyte counts 51 subclinical hypothyroidism 51 Operative mortality 51 OSAHS 51 pyelonephritis 51 Partial Response 51 cell carcinomas 51 thromboses 51 underwent radical prostatectomy 51 cytoreduction 51 % CI #.#-#.# [007] 51 imiquimod cream 51 anagrelide 51 methicillin susceptible Staphylococcus aureus 51 T1DM 51 cytomegalovirus infection 51 serum concentrations 51 guaiac 51 infectious syphilis 51 LRTI 51 cytokeratin 51 carcinoembryonic antigen 51 SGPT 51 sexually transmitted HPV 51 penile anal 51 antibiotic prophylaxis 51 axillary lymph node 51 #q# deletion 51 resected pancreatic cancer 51 Parathyroid Hormone 51 D#N 51 ritonavir boosted 51 NSTE ACS 51 confidence interval #.#-#.# 51 Cholangiocarcinoma 51 HPV genotypes 51 variant allele 51 histopathologic examination 51 thrombotic events 51 dysplastic 51 digital rectal examination 51 cervical lymph nodes 51 P. falciparum malaria 51 leukocyte count 51 premalignant lesions 51 UGT#A# * 51 colorectal adenomas 51 echocardiographic parameters 51 varicella infection 51 ACR# responses 51 hereditary hemochromatosis 51 colorectal liver metastases 51 HPV 51 morphometric vertebral fractures 51 gastrectomy 51 urogenital infections 51 demyelinating 51 imipenem 51 radical cystectomy 51 penicillin resistant Streptococcus 51 tenofovir DF 51 HLA A2 51 immunochemical fecal occult 51 noncardiac 51 paroxysmal AF 51 squamous cell cancers 51 genital tract infections 51 gallstone disease 51 pancreatic adenocarcinoma 51 prostate adenocarcinoma 51 underwent coronary angiography 51 serogroup B 51 invasive fungal infection 51 cholangiocarcinoma 51 thrombophilia 51 prostate biopsies 51 S. aureus infections 51 ICDs implanted 51 Mutation Detection 51 femoral neck BMD 51 oesophageal adenocarcinoma 51 Genital warts 51 pathologic diagnosis 51 CR nPR 51 MRSA isolates 51 axillary dissection 51 viral titers 51 E. faecalis 51 clinically evaluable patients 51 genital lesions 51 antibody titers 51 B7 H3 51 serum urate levels 51 Pelvic Inflammatory Disease 51 p# biomarker 51 methicillin susceptible 51 cervical precancer 51 Gastric cancer 51 fluoroquinolone resistance 51 transrectal ultrasound guided 51 Pneumocystis carinii pneumonia 51 ABCB1 51 Ultrasonography 51 perinatal transmission 51 Hepatitis C Virus 51 bacillus Calmette Guerin 51 localized renal 51 Leydig cell 51 undergo prostate biopsy 51 E. faecium 51 BI/NAP#/# 51 Plasmodium vivax 51 sentinel nodes 51 IV bisphosphonates 51 Non Alcoholic Steatohepatitis 51 PASI scores 51 testicular tumors 51 CI #.#-#.# [001] 51 DAS# remission 51 BRAF V#E 51 GG genotype 51 cervical biopsies 51 gynecologic malignancy 51 serum aminotransferase levels 51 erythema nodosum 51 mutated K ras 51 simplex virus 51 neutropaenia 50 creatinine ratio 50 de novo AML 50 alemtuzumab treated 50 hepatitis C HCV 50 basal cell nevus syndrome 50 lymph node dissection 50 careHPV 50 Prehypertension 50 hypophosphatemia 50 Prostate Specific Antigen 50 endometrial ovarian 50 genital ulcer disease 50 Adjuvant chemotherapy 50 PCA3 scores 50 sCJD 50 serum creatinine levels 50 Klebsiella pneumonia 50 empyema 50 hereditary breast cancer 50 Ixiaro 50 DCIS lesions 50 lymphocyte count 50 grade gliomas 50 Erythema 50 monoinfected patients 50 lichen planus 50 Sezary syndrome 50 osteoporotic fractures 50 #:#-# [031] 50 serum ferritin 50 cytology 50 univariate analyzes 50 fosamprenavir 50 Hurthle cell 50 vaccine serotypes 50 carcinoid tumor 50 HbF 50 MYH9 gene 50 leucopenia 50 leukaemias 50 test FOBT 50 urine albumin 50 orchitis 50 idiopathic PAH 50 colorectal tumors 50 CCyR 50 systemic lupus erythematosus SLE 50 rectal cancers 50 Randomized trials 50 proliferative retinopathy 50 Index CDAI 50 PCR assay 50 tPSA 50 macroalbuminuria 50 carotid plaques 50 Staphylococcus epidermidis 50 diagnosed prenatally 50 elevated triglycerides 50 Allogeneic 50 HPV types 50 Univariate analysis 50 pneumoniae 50 atherothrombosis 50 pulmonary embolism PE 50 hepatocellular carcinoma 50 polypoid lesions 50 Trichomonas 50 BRCA2 gene mutation 50 proteinuria 50 rFSH 50 oropharyngeal squamous cell carcinoma 50 curative resection 50 testicular cancers 50 Polymorphisms 50 HbA 1c levels 50 hyperbilirubinemia 50 cervical vaginal 50 multivariable logistic regression 50 leukopenia 50 troponin T 50 BARACLUDE ® 50 liver metastasis 50 tryptase 50 diabetes mellitus DM 50 isoenzyme 50 hepatorenal syndrome 50 Radical prostatectomy 50 obstructive coronary artery 50 methicillin resistant S. aureus 50 achieved ACR# 50 resected 50 androgen deprivation 50 herpes zoster 50 undergoing coronary angiography 50 postoperative infections 50 unfavorable prognostic 50 HBeAg negative patients 50 Prostate Specific Antigen PSA 50 unresectable 50 pulmonary resection 50 oseltamivir resistant 50 catheter angiography 50 IgG antibody 50 bladder cancers 50 Anal cancer 50 gonococcal infection 50 lymphoproliferative disorders 50 poorer prognosis 50 abacavir Ziagen 50 null responder 50 micrometastases 50 Osteopenia 50 SNHL 50 visceral metastases 50 Kaposi sarcoma 50 excisional biopsy 50 Randomised Study 50 bronchioloalveolar carcinoma 50 lipid abnormalities 50 prevalences 50 genital infections 50 elevated hsCRP 50 dysuria 50 vivax 50 VZV 50 coagulase negative staphylococci 50 tipranavir ritonavir 50 MDR tuberculosis 50 bacterial vaginosis 50 TP# mutations 50 Erlotinib 50 HepC 50 recurrent glioblastoma multiforme 50 KRAS status 50 cryptorchidism 50 low expressors 50 Hepatitis B virus 50 upper gastrointestinal bleeding 50 ^ Tc 50 CaP 50 femoral neck fracture 50 nosocomial infection 50 chronic HCV infection 50 Zolinza 50 serogroup C 50 HER2 positive cancers 50 Cardiopulmonary bypass 50 gastrointestinal stromal tumors GISTs 50 Herpes zoster 50 multivariate analyzes 50 Human Papilloma Virus 50 Basal cell carcinoma 50 Clostridium difficile infections 50 neuroblastoma tumors 50 polytherapy 50 periodontal bacteria 50 bilateral oophorectomy 50 hyperplastic polyps 50 KIF6 gene 50 Carcinoma 50 ELISpot 50 distant metastasis 50 lymphocytic 50 bladder carcinoma 50 sentinel lymph nodes 50 metastatic RCC 50 dose ionizing radiation 50 μg dL 50 microbleeds 50 complete cytogenetic response 50 pyogenes 50 lymph node metastases 50 P = .# 50 Rectal cancer 50 methicillin sensitive 50 salmeterol HFA MDI 50 Subtype 50 metastatic malignant melanoma 50 nmol liter 50 IU ml 50 lamivudine resistant 50 postoperative infection 50 superficial vein thrombosis 50 N. gonorrhoeae 50 cystectomy 50 #OHD 50 virologic failure 50 asymptomatic carotid stenosis 50 axillary node 50 serum homocysteine 50 discontinued Viread 50 TURP 50 quadrivalent vaccine 50 HCV replicon 50 postoperative AF 50 oophorectomy 50 chest radiographs 50 serum IGF 50 multivariate adjustment 50 renal scarring 50 herpes zoster virus 50 BRCA2 mutation 50 molecular diagnostic assay 50 tracer uptake 50 clade C 50 latent celiac disease 50 Viral load 50 varices 50 severe periodontitis 50 AVODART 50 surface antigen HBsAg 50 TGFBR1 * 6A 50 multivessel disease 50 adjuvant radiotherapy 50 K. pneumoniae 50 vancomycin intermediate 50 MCyR 50 chlamydia infections 50 artery stenosis 50 M. leprae 50 epididymitis 49 ALI ARDS 49 P aeruginosa 49 hormone receptor positive 49 K#R [002] 49 serum antibody 49 nanograms milliliter 49 esophageal cancers 49 minimally symptomatic metastatic castrate 49 basal cell carcinomas 49 PEG IFN 49 bacterium Mycobacterium tuberculosis 49 NAbs 49 quinolone resistant 49 tumor recurrence 49 malignancy 49 pneumococcal carriage 49 lymphoma subtypes 49 hepatitis C genotype 49 coronary artery calcification 49 Ishak fibrosis score